News

Male Plus Naturally Combats the Effects of Alcohol on the Libido

Alcohol and Excessive Drinking Are Well-Known for Their Ability to Dampen Sexual Appetite. Male Plus Offers a Natural Solution.FORT LAUDERDALE,…

1 year ago

Male Plus Taps Into the Intimate Power of Tribulus Terrestris

The Natural Libido Enhancer’s Formula Includes a Potent Dose of the Ancient, Venerable, and World-Renowned HerbFort Lauderdale, FL, Jan. 23,…

1 year ago

CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal

Collaboration will support Sanofi’s use of CytoReason’s computational disease models to develop new targets for inflammatory bowel disease (IBD)TEL AVIV,…

1 year ago

Luke Welcomes New Board Members to Help Guide Rapid Growth

Stuart Archer and Angela Bailey join Board of Directors of healthcare and professional services firm dedicated to making a positive…

1 year ago

IntelGenx and Arwan Enter into a Supply Agreement for RIZAPORT® in MENA Countries

SAINT LAURENT, Quebec, Jan. 23, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical…

1 year ago

Cue Biopharma Announces Chief Medical Officer Transition

Matteo Levisetti, M.D., promoted to Chief Medical Officer, effective January 17, 2023Acting CMO Kenneth Pienta, M.D., to transition to a…

1 year ago

IO Biotech Announces Appointment of Devin Smith as General Counsel

Mr. Smith joins IO Biotech bringing over two decades of legal and compliance experience in the life science industriesNEW YORK,…

1 year ago

Rhythm Pharmaceuticals Announces Publication of Analysis of Quality of Life Improvements from Phase 3 Clinical Trial in Bardet-Biedl Syndrome

- Patients reported clinically meaningful improvements across multiple health-related quality of life measures following 52 weeks of treatment with setmelanotide…

1 year ago

Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics

BURNABY, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific…

1 year ago

12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology

WHITE PLAINS, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Iantrek today announced the publication of 12-month clinical results of a…

1 year ago